Original source: news.crunchbase.com — Exclusive: Nurx And Journey Clinical Co-Founders Raise $6M For Mental Health Startup Siggy
Siggy, a New York-based mental health startup, has raised $6 million in pre-seed funding to develop a service that uses artificial intelligence (AI) to collect patient histories and track progress between appointments with licensed clinicians, according to news.crunchbase.com.
What happened
Siggy announced it has secured $6 million in pre-seed funding to build an AI-driven mental health service. The funding round was led by Village Global, with participation from investors such as Albert Wenger of Union Square Ventures, Mercury co-founder Immad Akhund, Cityblock Health co-founder Toyin Ajayi (through Coalition Operators), PsyMed Ventures, Mystic Ventures, and Gokul Rajaram. Several investors in this round have previously backed one or both of Siggy’s co-founders.
The company was founded by Jonathan Sabbagh, previously of Journey Clinical, and Edvard Engesæth, previously of Nurx. Sabbagh co-founded Journey Clinical, which supports practices offering ketamine-assisted psychotherapy, while Engesæth co-founded Nurx, an online healthcare platform for birth control and other services. Siggy began development in late 2025, according to news.crunchbase.com.
Siggy’s platform uses AI to maintain ongoing conversations with patients and organize the information they share. This data is then available for clinicians to review between appointments. Patients start with a free AI conversation about their history, followed by a video meeting with a licensed clinician. The clinician reviews the information, makes a diagnosis, and prescribes medication if appropriate.
Between appointments, patients can check in daily with the AI to report on sleep, mood, medication, and physical feelings. The system can also integrate data from wearable devices such as Whoop, Oura, or Apple Watch. These inputs are combined into a daily “Siggy Score” out of 100, visible to both patient and clinician. The software flags significant score changes for clinical review. Weekly check-ins are provided during the first eight weeks of treatment.
Siggy accepts commercial insurance in all 50 states and is expanding into government insurance programs. The service will be free for veterans. The company does not prescribe controlled substances and is not a crisis service, according to its founders.
Why it matters for researchers
Siggy’s funding highlights the growing intersection of AI, digital health, and clinical practice. The platform’s use of AI to collect and organize patient-reported outcomes, along with wearable device data, reflects a trend toward personalized and continuous monitoring in mental healthcare. For researchers in biology, genetics, and biotech, this signals increasing industry demand for expertise in data integration, digital phenotyping, and the development of AI tools for clinical decision support. It also underscores the expanding role of startups in translating scientific and technological advances into patient-facing products, with significant funding opportunities for those with interdisciplinary skills.
Where to dig deeper
- Read the full report at news.crunchbase.com
- Track new papers on synthetic biology with Seamless
- Explore recent advances in AI-driven patient monitoring and digital health records in peer-reviewed journals
This article summarises public reporting. Facts as reported by news.crunchbase.com; read the original for full details.
